Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis☆
- 1 October 1999
- Vol. 20 (10) , 1247-1262
- https://doi.org/10.1016/s0196-9781(99)00130-8
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Isolation and properties of the FSH and LH-releasing hormonePublished by Elsevier ,2004
- Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-IIEuropean Journal Of Cancer, 1997
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal MenNew England Journal of Medicine, 1981
- Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activityBiochemical and Biophysical Research Communications, 1974
- Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase methodBiochemical and Biophysical Research Communications, 1971
- Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analysesBiochemical and Biophysical Research Communications, 1971